Institutional investors purchased a net $3.2 million shares of ARAV during the quarter ended March 2019. This may signal that the smart money is gaining interest in this company as the 13.02% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BVF PARTNERS LP Bought 4.8 Million shares of Aravive Inc
COLLECTIVE FAMILY OFFICE LLC Bought 12.0 Thousand shares of Aravive Inc
ASSENAGON ASSET MANAGEMENT SA (G... Sold 46.0 Thousand shares of Aravive Inc